No description
-
2019 (v1)PublicationUploaded on: April 14, 2023
-
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2018 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2018 (v1)Publication
Before the percutaneous era, the mortality rate of patients with coronary heart disease not suitable for cardiac surgery was extremely high. This limit has been progressively exceeded with the advent of minimally invasive approaches, which, although initially intended exclusively for low risk scenarios, was then employed in complex patients...
Uploaded on: April 14, 2023 -
2019 (v1)PublicationNeoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge
The recognition that obstructive disease of the epicardial coronary arteries, causing ischaemic heart disease, can be treated with a percutaneous coronary intervention (PCI) has been a major discovery in cardiology in the last 40 years contributing, in particular, to the reduction of mortality associated to acute myocardial infarction (AMI)....
Uploaded on: April 14, 2023 -
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
Anticoagulant therapy during the acute phase of non-ST elevation acute coronary syndromes (NSTE-ACS) is strongly recommended by current international guidelines. Evidence supporting the use of anticoagulant therapy in the early phase of NSTE-ACS however, is based on dated trials mostly performed in the nineties and recent randomised clinical...
Uploaded on: April 14, 2023